MARKET

LAB

LAB

STANDARD BIOTOOLS INC
NASDAQ
0.9620
+0.0121
+1.27%
After Hours: 0.9811 +0.0191 +1.99% 17:33 03/25 EDT
OPEN
0.9550
PREV CLOSE
0.9499
HIGH
0.9832
LOW
0.9457
VOLUME
1.23M
TURNOVER
--
52 WEEK HIGH
1.720
52 WEEK LOW
0.9200
MARKET CAP
375.25M
P/E (TTM)
-4.9007
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at LAB last week (0316-0320)?
Weekly Report · 2d ago
Cathie Wood's weekly recap: adds JOBY, CRSP, TEM, sells TER, TXG, CRCL
Seeking Alpha · 03/16 11:05
Weekly Report: what happened at LAB last week (0309-0313)?
Weekly Report · 03/16 09:34
Cathie Wood's weekly recap: adds to AMZN, BABA, HOOD, COIN, cuts TSM, BIDU
Seeking Alpha · 03/09 11:10
Weekly Report: what happened at LAB last week (0302-0306)?
Weekly Report · 03/09 09:35
Weekly Report: what happened at LAB last week (0223-0227)?
Weekly Report · 03/02 09:35
Standard BioTools (LAB) Q4 Profit Challenges Longstanding Unprofitable Narrative
Simply Wall St · 02/25 23:31
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Globus Medical (GMED), Standard BioTools (LAB) and Addus Homecare (ADUS)
TipRanks · 02/25 10:00
More
About LAB
Standard BioTools Inc. has a portfolio of technologies that help biomedical researchers develop medicines faster. The Company develops, manufactures and sells a diversified range of instrumentation, consumables, and services. The Company's Genomics business includes instruments, consumables, software, and services based upon technologies used in the identification of genes (DNA, RNA) and their functions. Its Biomark X9 system for high-throughput genomics delivers scalability for qPCR applications. Designed for researchers who require robust multiplexing capabilities, the Biomark X9 system enables the simultaneous analysis of thousands of reactions in a single run. By leveraging advanced microfluidics technology, it reduces reagent consumption while increasing throughput, making it a solution for large-scale genomic studies, clinical research, and biomarker discovery. The Biomark X9 system integrates with data analysis tools, accelerating workflows and providing comprehensive insights.

Webull offers Standard Biotools Inc stock information, including NASDAQ: LAB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LAB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LAB stock methods without spending real money on the virtual paper trading platform.